Cabaletta Bio Stock Investor Sentiment

CABA Stock  USD 1.67  0.01  0.60%   
About 63% of Cabaletta Bio's investor base is looking to short. The analysis of the overall investor sentiment regarding Cabaletta Bio suggests that many traders are alarmed. The current market sentiment, together with Cabaletta Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use Cabaletta Bio stock news signals to limit their universe of possible portfolio assets.

Comfort Level 37

 Alarmed

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Cabaletta Bio's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Cabaletta Bio.

Cabaletta Historical Sentiment

Although Cabaletta Bio's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Cabaletta, such as negative comments on social media and news outlets, may cause fear in the market and push Cabaletta Bio's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Cabaletta.

Cabaletta Bio Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Cabaletta Bio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of Cabaletta Bio's Stock prices. Below is the latest headlines and news related to Cabaletta Bio Stock. Current markets are slightly bullish. About 55% of major world exchanges and indexes are currently up. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about Cabaletta Bio that are available to investors today. This information is accessible both publicly - through Cabaletta Bio's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Cabaletta-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Cabaletta Bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Cabaletta Bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Cabaletta Bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Cabaletta Bio alpha.

Cabaletta Largest EPS Surprises

Earnings surprises can significantly impact Cabaletta Bio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2021-03-16
2020-12-31-0.36-0.4-0.0411 
2020-08-06
2020-06-30-0.39-0.350.0410 
2022-08-11
2022-06-30-0.5-0.450.0510 
2021-11-01
2021-09-30-0.5-0.450.0510 
2021-08-05
2021-06-30-0.5-0.450.0510 
2021-05-03
2021-03-31-0.46-0.410.0510 
View All Earnings Estimates
a day ago at thelincolnianonline.com         
Analysts Set Cabaletta Bio, Inc. Target Price at 14.43
news
3 days ago at news.google.com         
Cabaletta Bios RESET-Myositis Study A Promising Step in Autoimmune Treatment - TipRanks
Google News at Macroaxis
few days ago at news.google.com         
Cabaletta Bios RESET-MG Study A Promising Step in Myasthenia Gravis Treatment - TipRanks
Google News at Macroaxis
few days ago at news.google.com         
Cabaletta Bios RESET-Myositis Study A Potential Game-Changer in Autoimmune Disease Treatment - TipRa...
Google News at Macroaxis
six days ago at news.google.com         
Cabaletta Bio Stock Price Up 1.3 percent - Heres What Happened - MarketBeat
Google News at Macroaxis
over a week ago at news.google.com         
Cabaletta Bio, Inc. Receives Average Recommendation of Buy from Analysts - MarketBeat
Google News at Macroaxis
over two weeks ago at news.google.com         
Cabaletta Bio Prices Public Offering to Raise 100 Million - MSN
Google News at Macroaxis
over three weeks ago at news.google.com         
Cabaletta Bio slides on proposed securities offering - MSN
Google News at Macroaxis
over three weeks ago at thelincolnianonline.com         
Cabaletta Bio, Inc. Receives 20.33 Consensus Price Target from Analysts
news
over three weeks ago at news.google.com         
Cabaletta Bio, Inc. Receives Consensus Recommendation of Buy from Analysts - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
Cabaletta Bios 10 percent Surge A Mystery Move Amid Biotech Sector Decline - AInvest
Google News at Macroaxis
over a month ago at news.google.com         
Cantor Fitzgerald Weighs in on Cabaletta Bio FY2026 Earnings - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
Cabaletta Bio stock price target reiterated on strong clinical data - Investing.com
Google News at Macroaxis
over a month ago at gurufocus.com         
Cabaletta Bio Shares Drop 20 percent After Public Offering Announcement
Gurufocus Stories at Macroaxis
over a month ago at gurufocus.com         
Cabaletta Bio Receives Reiterated Buy Rating from HC Wainwright Co. CABA Stock News
Gurufocus Stories at Macroaxis
There is far too much social signal, news, headlines, and media speculation about Cabaletta Bio that are available to investors today. This information is accessible both publicly - through Cabaletta Bio's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Cabaletta-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Cabaletta Bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Cabaletta Bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Cabaletta Bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Cabaletta Bio alpha.

Cabaletta Bio Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Cabaletta Bio Targets 2027 for Rese-cel BLA Submission CABA Stock News
05/15/2025
2
Disposition of 150000 shares by Chang David J. of Cabaletta Bio at 11.09 subject to Rule 16b-3
05/19/2025
3
Cabaletta Bio Showcases First-Ever Curative Autoimmune Cell Therapies at Major Jefferies Conference - Stock Titan
05/29/2025
4
Acquisition by Henriques Richard C Jr of 22000 shares of Cabaletta Bio at 2.37 subject to Rule 16b-3
06/09/2025
5
Cabaletta Bio Announces Proposed Public Offering of Securities CABA Stock News
06/11/2025
6
Cabaletta Bio stock price target reiterated on strong clinical data - Investing.com
06/13/2025
7
Cabaletta Bio, Inc. Receives Consensus Recommendation of Buy from Analysts - MarketBeat
06/20/2025
8
Cabaletta Bios RESET-Myositis Study A Potential Game-Changer in Autoimmune Disease Treatment - TipRanks
07/15/2025

Complementary Tools for Cabaletta Stock analysis

When running Cabaletta Bio's price analysis, check to measure Cabaletta Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cabaletta Bio is operating at the current time. Most of Cabaletta Bio's value examination focuses on studying past and present price action to predict the probability of Cabaletta Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cabaletta Bio's price. Additionally, you may evaluate how the addition of Cabaletta Bio to your portfolios can decrease your overall portfolio volatility.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
CEOs Directory
Screen CEOs from public companies around the world